Summary In this report we describe a case of factor VIII inhibitor appearing in a man with leprosy, with comments on the clinical presentation of the disease, laboratory findings and outcome of the patient.
A 76-year-old man with lepromatous leprosy was admitted to the hospital on 23 May 1986 with hematuria and ecchymoses. The patient had received DDS therapy for 27 years. There was no history of bleeding in the past and no family history of bleeding diathesis. The findings from coagulation studies (Tables I and 2 ) demonstrated the presence of an inhibitor of fa ctor VIII. The screening for other autoantibodies, like ANF and RF, were negative. The treatment with DDS was promptly discontinued and substituted with clofazimine, and an infusion of cryoprecipitate was commenced, 50 U /kg every 12 hr. The prolonged activated partial thromboplastin time (APTT) was not corrected by the treatment, but there was a definite clinical improvement. Then azathioprine (200 mg/day) and prednisone (1 mg/Kg/d) were introduced, with the aim of reducing the patient's factor VIII inhibitor level. During the next year he had several skin ecchimoses and 13 months later he developed a large hematoma in the left hemithorax that required a transfusion of packed red blood ceIIs. The plasma fa ctor VIII activity was 7%, his factor VIn inhibitor level did not change from its original value of 4 BU /mL, and the medication was discontinued. The patient died 2 years later of heart failure, which was unrelated to the presence of the inhibitor.
Laboratory investigation
Activated Partial Thromboplastin Time (APTT) was measured with kaolin and human brain cephalin; I factor VIII level by a described procedure;2 antifactor VIII inhibitor 0305-75 18/9 1 /062 155+03 $0 1 .00 © Lepra assay by the Bethesda system; 3 and other tests were done using conventional methods. Table I lists the initial studies performed on this patient and shows a factor VIII levei of 3%. Table 2 shows the facto r VIII and inhibitor leveis during the patient observation.
ConcIusions
The spontaneous appearance of antibodies to factor VIII: C in nonhemophiliac patients is recognized as a rare but serious cause of hemorrhagic diathesis.4-7 It is c1inica\ly distinct from inherited hemophilia, being characterized by few hemarthroses but frequent skin and other soft tissue hematomas. Acquired hemophilia is thought to be autoimmune, in which autoantibodies directed against the facto r VIII molecule spontaneously deve\op for unknown reasons. It can occur in association with drugs, collagen vascular diseases, Iymphoproliferative disorders, and the postpartum state, as we\l as in healthy persons.7 -10
Although circulating anticoagulants have been described in lepromatous leprosy, 11 -1 3 for the first time this report finds that it was a factor VIII inhibitor. Tt is unlikely that sulphonamide was the cause of the production of factor VIII antibody, as in other cases of inhibitor associated with drugs, since the patient had used the medication for 27 years, with no side-effects. The erythema nodosum leprosum reaction has been associated with spontaneous reversible c10tting abnormalities,14,15 but this patient has no sign of this complication. Therefore, maybe, there was a cause-and-effect relationship between the disease and the inhibitor, since leprosy patients, in particular lepromatous, have several immunological alterations, with increased titers of autoantibodies.16,17 However, in vitro studies, to confirm that the factor VIII inhibitor was indeed an antibody, were not carried out.
